These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25586662)

  • 41. Overexpression of S100A4 as a biomarker of metastasis and recurrence in oral squamous cell carcinoma.
    Natarajan J; Hunter K; Mutalik VS; Radhakrishnan R
    J Appl Oral Sci; 2014; 22(5):426-33. PubMed ID: 25466476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.
    Lindenblatt Rde C; Martinez GL; Silva LE; Faria PS; Camisasca DR; Lourenço Sde Q
    J Oral Pathol Med; 2012 Jan; 41(1):34-9. PubMed ID: 21902722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic value of histopathological grading systems in oral squamous cell carcinomas.
    Sawazaki-Calone I; Rangel A; Bueno AG; Morais CF; Nagai HM; Kunz RP; Souza RL; Rutkauskis L; Salo T; Almangush A; Coletta RD
    Oral Dis; 2015 Sep; 21(6):755-61. PubMed ID: 25825335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship of Galectin-3 Expression in Canine Cutaneous Squamous Cell Carcinomas with Histopathological Grading and Proliferation Indices.
    Marques GR; Rocha LF; Vargas THM; Pulz LH; Huete GC; Cadrobbi KG; Pires CG; Sanches DS; Mota EFF; Strefezzi RF
    J Comp Pathol; 2020 Jul; 178():16-21. PubMed ID: 32800103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical Analysis of Galectins-1, -3, and -7 in Periapical Granulomas, Radicular Cysts, and Residual Radicular Cysts.
    Brito LNS; de Lemos Almeida MMR; de Souza LB; Alves PM; Nonaka CFW; Godoy GP
    J Endod; 2018 May; 44(5):728-733. PubMed ID: 29510866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines.
    Kasamatsu A; Uzawa K; Nakashima D; Koike H; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
    Int J Mol Med; 2005 Aug; 16(2):269-73. PubMed ID: 16012760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of EGFR in prognostic characterization in histopathological variants of oral squamous cell carcinoma.
    Tyagi D; Singhal M; Gulati N; Jain A; Shetty DC
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S743-S746. PubMed ID: 38384049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
    Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
    J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
    Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
    J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical study on neuropilin 1 (NRP1) immunoexpression in oral squamous cell carcinoma.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    Folia Histochem Cytobiol; 2018; 1(2):98-105. PubMed ID: 29873058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.
    Langbein S; Brade J; Badawi JK; Hatzinger M; Kaltner H; Lensch M; Specht K; André S; Brinck U; Alken P; Gabius HJ
    Histopathology; 2007 Nov; 51(5):681-90. PubMed ID: 17927590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical Protein Kinase C λ/ι Expression Is Associated with Malignancy of Oral Squamous Cell Carcinoma.
    Baba J; Kioi M; Akimoto K; Nagashima Y; Taguri M; Inayama Y; Aoki I; Ohno S; Mitsudo K; Tohnai I
    Anticancer Res; 2018 Nov; 38(11):6291-6297. PubMed ID: 30396949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system.
    Squarize CH; Castilho RM; Santos Pinto D
    J Oral Pathol Med; 2002 Aug; 31(7):379-84. PubMed ID: 12224530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
    Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
    Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic efficacy of nuclear morphometry at invasive front of oral squamous cell carcinoma: an image analysis microscopic study.
    Vedam VK; Boaz K; Natarajan S
    Anal Cell Pathol (Amst); 2014; 2014():247853. PubMed ID: 25763315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The stromal immunoexpression of CLIC4 may be related to the difference in the biological behavior between oral squamous cell carcinoma and oral verrucous carcinoma.
    Xerez MC; Barros CC; Queiroz SI; Silveira ÉJ; Costa AD
    Med Oral Patol Oral Cir Bucal; 2023 Sep; 28(5):e418-e424. PubMed ID: 37026609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
    Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Galectin-3 upregulation during tumor progression in head and neck cancer.
    Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
    Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.